FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

64130008: Troleandomycin (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
106604016 Troleandomycin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
106606019 Triacetyloleandomycin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
106607011 T.A.O. en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
803489018 Troleandomycin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
847901000172118 troléandomycine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Troleandomycin Is a médicament antibactérien false Inferred relationship Some
Troleandomycin Is a Oleandomycin false Inferred relationship Some
Troleandomycin This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) true Inferred relationship Some
Troleandomycin Is a Antibacterial false Inferred relationship Some
Troleandomycin Is a Macrolide (substance) false Inferred relationship Some
Troleandomycin Is a Substance with macrolide structure and antibacterial mechanism of action (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing troleandomycin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Troleandomycin Inferred relationship Some 1
Troleandomycin 250 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Troleandomycin Inferred relationship Some
Troleandomycin 250 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Troleandomycin Inferred relationship Some 1
Troleandomycin 250 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Troleandomycin Inferred relationship Some 1
Troleandomycin 250 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Troleandomycin Inferred relationship Some 1
Troleandomycin-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Troleandomycin Inferred relationship Some 1
Troleandomycin only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Troleandomycin Inferred relationship Some 1
Troleandomycin only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Troleandomycin Inferred relationship Some 1

This concept is not in any reference sets

Back to Start